Mali

5 Vaccines Approved for Use in Mali

Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reliefweb.int
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: french.peopledaily.com.cn
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Approval Source: reliefweb.int

5 in Clinical Trials in Mali

Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Jcovden

Approved in 113 countries
26 trials in 25 countries
Protein Subunit

Shanghai Zerun Biotechnology, Walvax Biotechnology

202-CoV

6 trials in 2 countries
Protein Subunit

Shanghai Zerun Biotechnology, Walvax Biotechnology

202a-CoV

2 trials in 1 country